Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Cheng

Showing results (771-780 of 829) with videos related to

Pageof 83
Sort By:
Clinical Rheumatology|October 7, 2006
Plasma homocysteine status in patients with ankylosing spondylitisJames Cheng-Chung Wei, Ming-Shiou Jan, Chen-Tung Yu, et al.
RMD Open|June 2, 2022
Effect of tofacitinib on pain, fatigue, health-related quality of life and work productivity in patients with active ankylosing spondylitis: results from a phase III, randomised, double-blind, placebo-controlled trialVictoria Navarro-Compán, James Cheng-Chung Wei, Filip Van den Bosch, et al.
Cellular & Molecular Immunology|December 22, 2005
The study of IgG subclass profiles of anti-hbc in populations with different status of HBV infectionYu-Yen Yang, Chien-Fu Huang, James Cheng-Chung Wei, et al.
The Lancet Regional Health. Western Pacific|February 15, 2024
Safety and efficacy of peficitinib in Asian patients with rheumatoid arthritis who had an inadequate response or intolerance to methotrexate: results of a multicenter, randomized, double-blind, placebo-controlled phase 3 studyYue Yang, Jingyang Li, Ju Liu, et al.
Journal of the Chinese Medical Association : JCMA|January 29, 2020
Adenovirus infection and subsequent risk of Kawasaki disease: A population-based cohort studyShih-Hui Huang, Chun-Yu Chen, Ken-Pen Weng, et al.
Eye (London, England)|January 9, 2025
Monkeypox infection and risk for uveitisAlan Y Hsu, Chun-Chi Chiang, Yi-Ching Shao, et al.
Annals of the Rheumatic Diseases|October 18, 2017
An Assessment in SpondyloArthritis International Society (ASAS)-endorsed definition of clinically important worsening in axial spondyloarthritis based on ASDASAnna Molto, Laure Gossec, Bhowmik Meghnathi, et al.
Medicina (Kaunas, Lithuania)|May 25, 2024
Assessing Uveitis Risk following Pediatric Down Syndrome Diagnosis: A TriNetX Database StudyAlan Y Hsu, Yu-Hsun Wang, Chun-Ju Lin, et al.
Rheumatology (Oxford, England)|July 28, 2011
Effects of genetic polymorphisms of programmed cell death 1 and its ligands on the development of ankylosing spondylitisChun-Huang Huang, Ruey-Hong Wong, James Cheng-Chung Wei, et al.
Rheumatology and Therapy|June 30, 2019
Translating Improvements with Ixekizumab in Clinical Trial Outcomes into Clinical Practice: ASAS40, Pain, Fatigue, and Sleep in Ankylosing SpondylitisPhilip Mease, Jessica A Walsh, Xenofon Baraliakos, et al.
Pageof 83

Showing results (771-780 of 829) with videos related to

Sort By:
Pageof 83
Clinical Rheumatology|October 7, 2006
Plasma homocysteine status in patients with ankylosing spondylitisJames Cheng-Chung Wei, Ming-Shiou Jan, Chen-Tung Yu, et al.
RMD Open|June 2, 2022
Effect of tofacitinib on pain, fatigue, health-related quality of life and work productivity in patients with active ankylosing spondylitis: results from a phase III, randomised, double-blind, placebo-controlled trialVictoria Navarro-Compán, James Cheng-Chung Wei, Filip Van den Bosch, et al.
Cellular & Molecular Immunology|December 22, 2005
The study of IgG subclass profiles of anti-hbc in populations with different status of HBV infectionYu-Yen Yang, Chien-Fu Huang, James Cheng-Chung Wei, et al.
The Lancet Regional Health. Western Pacific|February 15, 2024
Safety and efficacy of peficitinib in Asian patients with rheumatoid arthritis who had an inadequate response or intolerance to methotrexate: results of a multicenter, randomized, double-blind, placebo-controlled phase 3 studyYue Yang, Jingyang Li, Ju Liu, et al.
Journal of the Chinese Medical Association : JCMA|January 29, 2020
Adenovirus infection and subsequent risk of Kawasaki disease: A population-based cohort studyShih-Hui Huang, Chun-Yu Chen, Ken-Pen Weng, et al.
Eye (London, England)|January 9, 2025
Monkeypox infection and risk for uveitisAlan Y Hsu, Chun-Chi Chiang, Yi-Ching Shao, et al.
Annals of the Rheumatic Diseases|October 18, 2017
An Assessment in SpondyloArthritis International Society (ASAS)-endorsed definition of clinically important worsening in axial spondyloarthritis based on ASDASAnna Molto, Laure Gossec, Bhowmik Meghnathi, et al.
Medicina (Kaunas, Lithuania)|May 25, 2024
Assessing Uveitis Risk following Pediatric Down Syndrome Diagnosis: A TriNetX Database StudyAlan Y Hsu, Yu-Hsun Wang, Chun-Ju Lin, et al.
Rheumatology (Oxford, England)|July 28, 2011
Effects of genetic polymorphisms of programmed cell death 1 and its ligands on the development of ankylosing spondylitisChun-Huang Huang, Ruey-Hong Wong, James Cheng-Chung Wei, et al.
Rheumatology and Therapy|June 30, 2019
Translating Improvements with Ixekizumab in Clinical Trial Outcomes into Clinical Practice: ASAS40, Pain, Fatigue, and Sleep in Ankylosing SpondylitisPhilip Mease, Jessica A Walsh, Xenofon Baraliakos, et al.
Pageof 83